Navigation Links
Emerging staph strains found to be increasingly deadly and deceptive

A study of how the immune system reacts to strains of antibiotic-resistant Staphylococcus aureus bacteria--emerging strains that sicken otherwise healthy people, or so-called "community-acquired" infections--has shown for the first time that these strains are more deadly and better at evading human immune defenses than more common S. aureus strains that originate in hospitals and other health-care settings.

In a paper released today online in The Journal of Immunology, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, describe how community-acquired S. aureus strains that survive treatment with the methicillin family of antibiotics can evade immune defenses. Infections from community-acquired methicillin-resistant S. aureus, or MRSA, are difficult to treat and are increasing nationally at an alarming rate, say experts.

Scientists at NIAID's Rocky Mountain Laboratories (RML) in Hamilton, MT, and colleagues examined the ability of MRSA strains to cause disease in mice and avoid destruction by human white blood cells called neutrophils. Neutrophils, which typically ingest and then kill harmful bacteria, make up about 60 percent of all white blood cells and are the first line of defense against bacteria. Scientists know that community-acquired strains differ from hospital strains, but they don't know why the community strains cause more serious infection in otherwise healthy people.

The work also identified specific S. aureus genes that potentially control the bacterium's escape from neutrophils. Among thousands of S. aureus genes analyzed in the five different strains used in the study, the scientists identified a large group of genes whose role in helping spread infection is unknown. RML's Frank DeLeo, Ph.D., the investigator who directed the study, and colleagues plan to determine if some of the unknown genes help promote disease. If they can learn which genes control t
'"/>

Source:NIH/National Institute of Allergy and Infectious Diseases


Page: 1 2 3

Related biology news :

1. Ticks, flukes, and genomics: Emerging pathogens revealed
2. Substance protects resilient staph bacteria
3. Study indicates dramatic rise in antibiotic-resistant community-acquired staph infections
4. Less virulent strains of avian influenza can infect humans
5. Study outlines genetic differences between potential pandemic influenza strains
6. Human behavior changes the number of strains of infectious diseases
7. Experimental vaccine protects lab animals against several strains of H5N1
8. Complexity constrains evolution of human brain genes
9. New test for most virulent HPV strains under study
10. New component of the brakes on nerve regeneration found
11. Strongest proof yet found for prion hypothesis
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Emerging staph strains found increasingly deadly and deceptive

(Date:6/18/2013)... very large "dead zone" in the Gulf of Mexico ... Chesapeake Bay this year, based on several NOAA-supported forecast ... Louisiana State University, and the Louisiana Universities Marine ... hypoxic "dead" zone will be between 7,286 and 8,561 ... largest recorded. That would range from an area the ...
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
(Date:6/18/2013)... Molecular Pathology is proud to announce it will join ... on July 1, 2013. The FASEB Board approved AMP,s ... The 26 constituent societies of FASEB represent more than ... advancement of research and education in biological and biomedical ... now than ever," said Jennifer L. Hunt, MD, MEd, ...
Breaking Biology News(10 mins):NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 2NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 3NOAA, partners predict possible record-setting deadzone for Gulf of Mexico 4NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... 1, 2011 JERUSALEM, Israel EUREKA the ... supported by 40 member states and mobilizing more than ... today announced the launch of "E!nnoVest", its new ... This web-based instrument allows investors to identify highly-qualified and ...
... DALLAS June 1, 2011 A drug already ... a therapy for a common form of dementia, UT ... acid (SAHA) holds promise as a first-generation drug for ... a progressive, inherited neurodegenerative disease for which there is ...
... Plant Biologists (ASPB) has named the recipients of its 2011 ... program assists promising undergraduate students so they can conduct meaningful ... a key element of the program, and a solid mentoring ... work with a mentor who is an ASPB member. ...
Cached Biology News:Cancer drug holds promise as first treatment for common, inherited dementia 2ASPB awards 15 summer undergraduate research fellowships 2ASPB awards 15 summer undergraduate research fellowships 3ASPB awards 15 summer undergraduate research fellowships 4
(Date:6/19/2013)... A new look at “big glass” ... trends will highlight technical sessions at SPIE Photomask ... its 33rd year, the three-day event is the industry’s ... suppliers, approximately 100 technical presentations and numerous networking lunches ... for optics and photonics , the meeting will be ...
(Date:6/18/2013)... million electric cars could be on roads across North America ... research by the United States Department of Energy, Los Alamos ... Chen is part of a team led by the Los ... the expensive platinum catalysts in fuel cells. , "One of ... vehicles is the cost of the units. The pure platinum ...
(Date:6/18/2013)... June 18, 2013 The Regulatory ... of two new offices in Asia—one in Singapore and ... serve as RAPS’ Pan-Asia office , serving the ... more focused on audiences within China. , The announcement ... partnership with five Singapore government agencies to develop and ...
(Date:6/18/2013)... Phoenix, AZ (PRWEB) June 18, 2013 ... the 2013 Innovation Challenge Winner out of hundreds of ... in its spring Arizona Innovation Challenge . The ... the country for a technology commercialization challenge, granting a ... world’s most promising technology ventures. Nasseo’s state of the ...
Breaking Biology Technology:‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3US and Canadian researchers drive towards cheaper fuel cells for electric cars 2RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3Nasseo Named 2013 Innovation Challenge Winner by Arizona Commerce Authority 2
... OAKS, Calif., Dec. 11 Ceres, Inc. announced today,that ... under its,Blade Energy Crops label. The highly anticipated launch ... specifically as raw materials,for biofuels and biopower. The company ... The company reported ...
... 11 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... Directors, unexpectedly passed away on Wednesday. Dr. Waltz had been ... At the time of his death, Dr. Waltz served on ... , "The sudden loss of our ...
... CARY, N.C., Dec. 11 Cornerstone Therapeutics Inc. ... company focused on developing and commercializing prescription medications ... the status of its integration activities following the ... Inc. and Cornerstone BioPharma Holdings, Inc. on October ...
Cached Biology Technology:First Seed Sales of Dedicated Energy Crops Begin 2First Seed Sales of Dedicated Energy Crops Begin 3Peregrine Pharmaceuticals Mourns Loss of Chairman Thomas A. Waltz 2Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 2Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 3Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 4Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance 5
... antibody development to targets including proteins and ... and cancer-specific surface antigens. A&Gs service ... completed in approximately 40 days (duration may ... antigens). Phase I: Immunization, test bleed ...
... ZMD.368. Immunogen: Synthetic peptide derived ... human WNT2B/WNT13 protein. Specificity: Specific ... and rat WNT2B/WNT13 proteins. Recognizes both ... Reactivity: Mouse Human Rat (positive controls: ...
... Synthetic peptide derived from the N-terminal ... 17 open reading frame 37 (C17orf37 protein) ... C35 protein. On Western blots it identifies ... Reactivity: Human (positive control: full-length human ...
...
Biology Products: